Application no. and date | 15793746.7 (espacenet) (Federated) (European Patent Register), 20151104 | Patent/reg. no. and date | DK/EP 3230318, 20200624 | Publication date | 20171018 | Priority no. and date | GB 201422084, 20141211, GB 201506127, 20150410, JP 2015118495, 20150611 | EP pub. no. and date |
EP 3230318 20171018 | Effective date | | Applicant/owner | Lytix Biopharma AS, Tromsø¸ Science Park P.O. Box 6447 9294 Tromsø, NO | Applicant ref. no. | P74040DK01 | Inventor | ZITVOGEL, Laurence, Institut Gustave Roussy
F-94805 Villejuif, FR, YAMAZAKI, Takahiro, Institut Gustave Roussy
F-94805 Villejuif, FR, CAMILIO, Ketil, Molecular Inflammation Research Group Faculty of Health Sciences University of Tromsø
N9037 Tromsø, NO, SVEINBJÿRNSSON, Baldur, Molecular Inflammation Research Group Faculty of Health Sciences University of Tromsø
N9037 Tromsø, NO, REKDAL, ÿystein, Lundekroken 25 Leil 2301
N-1396 Billingstad, NO, SVENDSEN, John Sigurd Mjøen, Smørblomstvegen 36
N-9100 Kvaløysletta, NO, EIKE, Liv Marie, Molecular Inflammation Research Group Faculty of Health Sciences University of Tromsø
N9037 Tromsø, NO | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/08 (2019.01) , C07K 16/28 (2006.01) | Title | IMMUNE CHECKPOINT-INHIBITOR-KOMBINATIONER | Int. application no. | EP2015075722 | Int. publication no. | WO2016091487 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|